Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MannKind Corp (NASDAQ:MNKD)

0.5228
Delayed Data
As of Feb 27
 +0.0087 / +1.69%
Today’s Change
0.41
Today|||52-Week Range
2.24
-17.89%
Year-to-Date
No recent news for MannKind Corp.

Today’s Trading

Previous close0.51
Today’s open0.52
Day’s range0.51 - 0.54
Volume1,921,789
Average volume (3 months)4,924,638
Market cap$246.1M
Dividend yield--
Data as of 4:00pm ET, 02/27/2017

Growth & Valuation

Earnings growth (last year)-78.43%
Earnings growth (this year)+112.64%
Earnings growth (next 5 years)+26.80%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
IDRAIdera Pharmaceutical...-0.02-1.20%
TTPHTetraphase Pharmaceu...+0.06+1.13%
PETXAratana Therapeutics...+0.30+4.58%
CMRXChimerix Inc+0.21+3.85%
Data as of 4:00pm ET, 02/27/2017

Financials

Next reporting dateMarch 20, 2017
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$0.00
Annual profit (last year)-$368.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
CEO, CFO, Director, VP &
Head-Investor Relations
Matthew J. Pfeffer
Chief Medical Officer &
Vice President
Raymond W. Urbanski
Corporate headquarters
Valencia, California

Forecasts


Search for Jobs